Please select your page
  • Slide
    OTR3 is an innovative company
    dedicated to the development of
    the Matrix Therapy in regenerative medicine
    with a new class of therapeutic agents,
    the RGTA ® (ReGeneraTing Agents)
  • Slide
    CACIPLIQ20®
    is the newest technology
    in regenerative medicine,
    resulting from 15 years
    of academic research.
  • Slide
  • Slide
    CACICOL20 ®
    is a new technology
    in the field of
    regenerative medicine
    discovered by the
    French Research University Center
    CNRS.
  • Slide

 

Organ, Tissue, Regeneration, Repair, Replacement

The Matrix Therapy Company in Regenerative Medecine

OTR3 is an innovative company dedicated to the development of the Matrix Therapy in regenerative medicine with a new class of therapeutic agents, the RGTA ® (ReGeneraTing Agents).


Our products

PRODUCT PAGE

Cutaneous cicatrisation kit, prescribed for the treatment of chronic skin wounds including arteritis and venous ulcers, diabetic foot and pressure ulcers.

 PRODUCT PAGE

Single-dose eye drops for ocular cicatrisation prescribed for chronic cornea lesion healing.